LifeMD grants 200,000 RSUs to marketing chief
Pisano Christopher A reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Pisano Christopher A reported acquisition or exercise transactions in this Form 4 filing.
LifeMD, Inc. reported that Chief Marketing Officer Christopher A. Pisano received a grant of 200,000 shares of common stock in the form of restricted stock units on March 30, 2026. The award carries no purchase price.
According to the vesting terms, 50,000 units vest on the grant date, and an additional 50,000 units also vest on the grant dateMarch 30, 2027. A further 50,000 units vest on March 30, 2027, with the remaining units vesting on March 30, 2028, aligning the compensation with continued service at the company.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 200,000 shares
Grant/Award
1 txn
Insider
Pisano Christopher A
Role
Chief Marketing Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 200,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Shares — 200,000 shares (Direct)
Footnotes (1)
- F1. The grant of restricted stock units vest 50,000 on grant date, an additional 50,000 restricted stock units vest on grant date, which are subject to clawback in their entirety should the Owner not be employed by the Issuer through March 30, 2027 for any reason, 50,000 on March 30, 2027 and the remainder on March 30, 2028.
Key Figures
RSU grant size: 200,000 shares
Grant price per share: $0.00 per share
Immediate vesting portion: 50,000 units
+4 more
7 metrics
RSU grant size
200,000 shares
Restricted stock units granted to CMO on March 30, 2026
Grant price per share
$0.00 per share
Reported transaction price for awarded common shares
Immediate vesting portion
50,000 units
Restricted stock units vesting on grant date
Grant-date clawback-eligible portion
50,000 units
Vest on grant date but subject to clawback if not employed through March 30, 2027
2027 vesting tranche
50,000 units
Restricted stock units vesting on March 30, 2027
2028 vesting tranche
Remaining units
Restricted stock units vesting on March 30, 2028
Shares held after transaction
200,000 shares
Total direct holdings following the award
Key Terms
restricted stock units, clawback, Chief Marketing Officer, grant, award, or other acquisition
4 terms
restricted stock units financial
"The grant of restricted stock units vest 50,000 on grant date"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
clawback financial
"which are subject to clawback in their entirety should the Owner not be employed"
A clawback is a contractual or legal right to recover money that was already paid out—often executive bonuses, incentives, or erroneous payments—when certain conditions change, such as fraud, accounting mistakes, or failure to meet performance targets. It matters to investors because clawbacks protect shareholder value by discouraging risky or misleading behavior, can affect future cash flow and executive incentives, and signal stronger governance, much like a store recalling a refund after discovering it was issued in error.
Chief Marketing Officer financial
"reporting person serves as Chief Marketing Officer of LifeMD, Inc."
A chief marketing officer (CMO) is the senior executive who leads a company's efforts to attract and keep customers by managing brand image, advertising, pricing signals and market research. Investors monitor the CMO because their strategies directly affect sales growth, customer loyalty and the success of product launches—think of the CMO as the person designing a store’s storefront and promotions to draw and retain shoppers, which impacts revenue and valuation.
grant, award, or other acquisition financial
"transaction code A is described as Grant, award, or other acquisition"
FAQ
What insider transaction did LifeMD (LFMD) disclose for Christopher A. Pisano?
LifeMD disclosed that Chief Marketing Officer Christopher A. Pisano received a grant of 200,000 restricted stock units of common shares. The award was reported at a price of $0.00 per share, reflecting compensation rather than an open-market purchase or sale, and increases his direct holdings.
How do the 200,000 LifeMD (LFMD) restricted stock units vest?
The 200,000 restricted stock units vest in stages. 50,000 units vest on the grant date, another 50,000 units also vest on the grant date, 50,000 units vest on March 30, 2027, and the remaining units vest on March 30, 2028, encouraging multi‑year retention.
What is the clawback condition on Christopher Pisano’s LifeMD (LFMD) award?
An additional 50,000 restricted stock units that vest on the grant date are subject to clawback if Pisano is not employed by LifeMD through March 30, 2027. If employment ends before then, those clawback‑eligible units can be forfeited, tying part of the grant to continued service.
Is the LifeMD (LFMD) grant to Christopher Pisano a market purchase or compensation award?
The transaction is a compensation award, not a market purchase. It is coded as a grant or award acquisition at a price of $0.00 per share, reflecting restricted stock units issued by LifeMD as part of Pisano’s executive compensation package rather than cash-funded buying or selling.
AI-generated analysis. How Rhea-AI works. Not financial advice.
